Oric Pharmaceuticals ORIC
$7.36 −$0.34 (-4.42%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $7.37 +0.14%
Open$7.58
Prev close$7.70
Day range$7.28 – $8.00
Volume1.46M
Market cap$764.94M
P/E (TTM)–
Dividend yield–
Earnings
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2021/Q4 | 21 Mar 2022 | After Market | – | -28.74% | – |
| 2020/Q2 | 5 Aug 2020 | After Market | – | +14.07% | – |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Fundamentals
Latest reported quarter: Q2, ended Jun 2026
Revenue$0.00
Operating profit-$45.30M-16.0% YoY
Net profit-$41.49M-14.1% YoY
Diluted EPS-$0.38+19.1% YoY
Free cash flow-$31.96M-3.4% YoY
Operating cash flow-$31.61M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Return on equity-39.8%
Return on assets-37.4%
Return on invested capital-39.4%
Current ratio13.19
Liabilities / assets5.8%
Cash & investments$264.76M
Net cash (debt)$264.76M
No comments yet — be the first to weigh in on ORIC.
Sign in to join the discussion.